Literature DB >> 33670930

CAPPRIC Study-Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings.

Jesús Molina1, Amelia González-Gamarra2, Leovigildo Ginel3, Mª Encarnación Peláez4, Juan Luis Juez5, Antonio Artuñedo6, Gonzalo Aldana7, Enriqueta Quesada8, Joan Josep Cabré9, Antonio Gómez10, Manuel Linares11, Maria Teresa Marín12, Pilar Yolanda Sanchez13, Leonor Núñez14, Jaime Gonzálvez15, Enrique Mascarós16, Javier López17, Agustina Cano18, José Herrero19, María Carmen Serra20, Enrique Cimas21, Marta Pedrol22, Juan Vicente Alfaro23, Federico Martinón-Torres24, Isabel Cifuentes25, Cristina Méndez25, Daniel Ocaña26.   

Abstract

The real burden of community-acquired pneumonia (CAP) in non-hospitalized patients is largely unknown. This is a 3-year prospective, observational study of ambulatory CAP in adults, conducted in 24 Spanish primary care centers between 2016-2019. Sociodemographic and clinical variables of patients with radiographically confirmed CAP were collected. Pneumococcal etiology was assessed using the Binax Now® test. Patients were followed up for 10 ± 3 days. A total of 456 CAP patients were included in the study. Mean age was 56.6 (±17.5) years, 53.5% were female, and 53.9% had ≥1 comorbidity. Average incidence of CAP was 1.2-3.5 cases per 1000 persons per year. Eighteen patients (3.9%) were classified as pneumococcal CAP. Cough was present in 88.1% of patients at diagnosis and fever in 70.8%. Increased pulmonary density (63.3%) and alveolar infiltrates with air bronchogram (16.6%) were the most common radiographic findings. After 14.6 ± 6.0 days (95% CI = 13.9-15.3), 65.4% of patients had recovered. Hospitalization rate was 2.8%. The most frequently prescribed antibiotics were quinolones (58.7%) and β-lactams (31.1%). In conclusion, one-third of CAP patients did not fully recover after two weeks of empiric antibiotic therapy and 2.8% required hospitalization, highlighting the significant burden associated with non-hospitalized CAP in Spain.

Entities:  

Keywords:  CAP; ambulatory; community-acquired pneumonia; non-hospitalized; outpatient; pneumococcal CAP

Year:  2021        PMID: 33670930      PMCID: PMC7997465          DOI: 10.3390/microorganisms9030508

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  26 in total

1.  Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China.

Authors:  Fei Zhou; Li Gu; Jiu Xin Qu; Ying Mei Liu; Bin Cao
Journal:  Clin Respir J       Date:  2016-08-08       Impact factor: 2.570

2.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Authors:  Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-07-14       Impact factor: 91.245

3.  [Multidisciplinary guidelines for the management of community-acquired pneumonia].

Authors:  Antoni Torres; José Barberán; Miquel Falguera; Rosario Menéndez; Jesús Molina; Pedro Olaechea; Alejandro Rodríguez
Journal:  Med Clin (Barc)       Date:  2012-12-29       Impact factor: 1.725

Review 4.  Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2020 Update.

Authors:  Rosario Menéndez; Catia Cilloniz; Pedro Pablo España; Jordi Almirall; Ane Uranga; Raúl Méndez; David Rigau; Antoni Torres
Journal:  Arch Bronconeumol       Date:  2020-03-03       Impact factor: 4.872

5.  The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).

Authors:  Ruth Gil-Prieto; Laura García-García; Alejandro Alvaro-Meca; Cristina Méndez; Ana García; Angel Gil de Miguel
Journal:  Vaccine       Date:  2010-11-25       Impact factor: 3.641

6.  The Alere BinaxNOW Pneumococcal Urinary Antigen Test: Diagnostic Sensitivity for Adult Pneumococcal Pneumonia and Relationship to Specific Serotypes.

Authors:  Hisashi Shoji; Arnau Domenech; Antonella Francesca Simonetti; Aida González; Dolores García-Somoza; Meritxell Cubero; Sara Martí; Masayuki Maeda; Fe Tubau; Josefina Liñares; Maria Angeles Domínguez; Jordi Carratalà; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

Review 7.  Dyspnoea: a multidimensional and multidisciplinary approach.

Authors:  Louis Laviolette; Pierantonio Laveneziana
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

Review 8.  Risk factors for community-acquired pneumonia in adults in Europe: a literature review.

Authors:  Antoni Torres; Willy E Peetermans; Giovanni Viegi; Francesco Blasi
Journal:  Thorax       Date:  2013-11       Impact factor: 9.139

9.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Infect Dis       Date:  2018-09-19       Impact factor: 71.421

Review 10.  Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging.

Authors:  Catia Cillóniz; Diana Rodríguez-Hurtado; Antoni Torres
Journal:  Med Sci (Basel)       Date:  2018-04-30
View more
  2 in total

Review 1.  [Current microbiological aspects of community respiratory infection beyond COVID-19].

Authors:  R Cantón
Journal:  Rev Esp Quimioter       Date:  2021-03-22       Impact factor: 1.553

2.  Magnetic Nanoclusters Increase the Sensitivity of Lateral Flow Immunoassays for Protein Detection: Application to Pneumolysin as a Biomarker for Streptococcus pneumoniae.

Authors:  María Salvador; José Luis Marqués-Fernández; Alexander Bunge; José Carlos Martínez-García; Rodica Turcu; Davide Peddis; María Del Mar García-Suárez; María Dolores Cima-Cabal; Montserrat Rivas
Journal:  Nanomaterials (Basel)       Date:  2022-06-14       Impact factor: 5.719

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.